| Hans-Günter Meyer-Thompson | Legal
USA. Study: More Pharma Money, More Gabapentin
USA. Study: More Pharma Money, More Gabapentin
Payments to doctors by pharmaceutical companies may be influencing them to prescribe more expensive, brand-name versions of the pain drug gabapentin, a team of researchers report in the July 8 issue of JAMA Internal Medicine,and the increasing use of the drug suggests it may be being abused. (University of Connectecut, USA, 08.07.2019)
https://today.uconn.edu/2019/07/study-more-pharma-money-more-gabapentin/